Drawing for CENTAGEN

USPTO serial 97464407

CENTAGEN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
WEIGLE, KATHERINE CONNOLLY
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CENTAGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Aileen Law

Aileen Law OPPEDAHL PATENT LAW FIRM LLCP O BOX 351240WESTMINSTER, CO 80035United States

Goods and services

ClassDescriptionStatusFirst use
005Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceutical preparations for the treatment of age-related diseases and disorders; Pharmaceutical preparations for the treatment of cardiovascular, oncological, immune system and inflammatory related diseases and disorders; Therapeutic pharmaceutical for the treatment of age-related diseases and disorders; Therapeutic pharmaceutical for the treatment of cardiovascular, oncological, immune system and inflammatory related diseases and disorders; Cardiovascular pharmaceutical preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 17, 2025MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 17, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 16, 2025NOACCORRECTED NOA E-MAILED—
Sep 16, 2025ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 16, 2025EX2GSOU EXTENSION 2 GRANTED—
Sep 16, 2025DPCCDIVISIONAL PROCESSING COMPLETE—
Sep 3, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 30, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 13, 2025DRRRDIVISIONAL REQUEST RECEIVED—
Feb 13, 2025ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Feb 13, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 12, 2025EXT2SOU EXTENSION 2 FILED—
Aug 12, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 12, 2024EX1GSOU EXTENSION 1 GRANTED—
Aug 12, 2024EXT1SOU EXTENSION 1 FILED—
Aug 12, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Feb 13, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 19, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 19, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 29, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 13, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 13, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 13, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 12, 2023ALIEASSIGNED TO LIE—
Jun 8, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 29, 2023GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2023GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2023CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 29, 2023DOCKASSIGNED TO EXAMINER—
Jul 6, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 21, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance